about
Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-NetMedical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumoursNeoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?Appendiceal neuroendocrine neoplasms: diagnosis and managementHyperandrogenism after menopauseThe validity of current guidelines regarding surgical management of patients with gastric neuroendocrine neoplasms type 1: a report of a series of seven patientsPseudo-Cushing’s StatesProgress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertensionLaparoscopic surgery for pancreatic insulinomas: an updateCurrent Issues in the Diagnosis and Management of Adrenocortical CarcinomasLong-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study.Safety and efficacy of everolimus in gastrointestinal and pancreatic neuroendocrine tumors after (177)Lu-octreotate.Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.Laparoscopic resection of large adrenal ganglioneuromaLeptin in pituitary adenomas--a novel paracrine regulatory system.Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene.Metabolic syndrome: definitions and controversies.The diagnosis and medical management of advanced neuroendocrine tumors.Secondary forms of polycystic ovary syndrome.Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.Clinical review: Diagnosis and management of pituitary carcinomas.The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.Ectopic ACTH syndrome.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.The diagnosis and management of malignant phaeochromocytoma and paraganglioma.Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series.Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations.The diagnosis and management of parasellar tumours of the pituitary.Antithyroid drug-induced aplastic anemia.Metastatic type 1 gastric carcinoid: a real threat or just a myth?Drug-induced esophagitis.Corticomedullary mixed adrenal tumor: case report and literature review.ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors.Paraneoplastic syndromes secondary to neuroendocrine tumours.Optic neuropathy following radiotherapy for Cushing's disease: case report and literature review.Skeletal diseases in Cushing's syndrome: osteoporosis versus arthropathy.Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease.Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
P50
Q21202846-8A51694C-A20B-41D8-BE20-C3502506CF4BQ26741498-4867AB89-03B3-4EF5-B2FF-9577F102B61DQ26770874-DA6E36FB-A698-405C-BD6F-F9A59098A58CQ26781673-F276D5C3-93E8-45BE-8EF2-4920BDD852D9Q26822584-16F6A780-FB63-46BF-9A50-9BF218999910Q26852066-553E8F0B-492A-4D5C-84C6-30C18C0F1852Q26997367-642A439F-89C2-4D61-A613-E46BE28BCE68Q27000628-69EBC45A-2D1D-45D3-8948-C27D2DB0BDFDQ28071354-2841A2F2-318D-4023-8DEF-BA3C9B0338B6Q28083986-BB5AC46C-5662-4A29-AC84-E838CB18B8EEQ30576503-49BD76C0-4191-44A9-8BE5-7C241450C701Q33410336-C5C7D01F-B4AC-428D-9231-C84C06D64043Q33606047-C33374BE-8009-4992-BF28-855B52E976A3Q34466005-0AE35FB7-3A0E-4308-A6AE-069C73AF204EQ34514798-C3F93F0E-7D18-4200-A5C3-A98AFD8E9C38Q34576778-E6A50F8E-A66F-40D6-A545-D6D956DC76EFQ35047747-B37DFD9E-D39F-419D-9E3A-607A153CF752Q35794419-F81A86A3-3FAE-4396-8E03-BED5A63E03D2Q35820504-612A3AB1-7410-4403-A3D9-7E75F09C0C29Q35833855-F0B32F7B-8A3F-4EF7-AA45-C2477D00CB4BQ36059156-79B32575-F646-437C-9EDA-DC9EFF20B881Q36320010-0445811F-C7E7-413D-AF06-44894B1F558CQ36523772-119A07BC-0593-4837-B32A-30FB221B43C1Q36849357-DD215C7F-D4E9-46BB-984D-028F585C896FQ36959623-94F43659-A423-452F-83D9-A941BE9DEE19Q37055377-E5882D8D-C435-4216-B61A-9D42DFEF3658Q37103639-A2F26D9E-3276-4725-BD81-2FEEC5D67AB8Q37276423-CADA09B8-625B-4CB4-BB76-636528A9F0F7Q37279047-B0ED9CA7-EC36-4349-84C0-9A78BF3036CBQ37408868-596353E8-AC8F-474C-A67C-7DA58538D243Q37458951-023A7110-E538-47AC-9E3F-97D32957DFDCQ37491975-C08455D9-8234-431E-ACC4-D06FE62E88D1Q37746699-E596DE31-CAAA-4EC2-B7EF-3FB473E0533BQ37763409-3FA3E456-E581-4A3C-B0F7-685AAB2BFBDBQ37778178-35E13227-B00D-4141-8FC0-7969C073D770Q37786933-45BCD513-8869-41EE-8930-4FBFC35D993EQ37839521-93FF8078-DF5A-40BB-85C5-AC1FB1AB3ED1Q37962416-83BE3F08-3909-4CA6-9D0D-9CD181F6AE9EQ38085587-8C8029C6-3F6D-4788-A063-7281D8CD364FQ38098709-E7E241B2-F5E2-4125-AFFA-23CDF4E3F67A
P50
description
researcher
@en
name
G Kaltsas
@en
G Kaltsas
@nl
type
label
G Kaltsas
@en
G Kaltsas
@nl
prefLabel
G Kaltsas
@en
G Kaltsas
@nl
P106
P31
P496
0000-0002-5876-7883